Evidence map›Paper›PMID 39499210›Full record

ArticleJournal of the American Chemical Society2024

Site-Specific Histidine Aza-Michael Addition in Proteins Enabled by a Ferritin-Based Metalloenzyme.

Jo-Chu Tsou, Chun-Ju Tsou, Chun-Hsiung Wang, An-Li A Ko, Yi-Hui Wang, Huan-Hsuan Liang, Jia-Cheng Sun, Kai-Fa Huang, Tzu-Ping Ko, Shu-Yu Lin and 1 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jo-Chu TsouInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Chun-Ju TsouInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Chun-Hsiung WangInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
An-Li A KoInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Yi-Hui WangInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.ORCID 0009-0002-2616-4129
Huan-Hsuan LiangInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Jia-Cheng SunInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Kai-Fa HuangInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Tzu-Ping KoInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.ORCID 0000-0003-1794-2638
Shu-Yu LinInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
Yane-Shih WangInstitute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.ORCID 0000-0003-2356-9577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histidine modifications of proteins are broadly based on chemical methods triggering N-substitution reactions such as aza-Michael addition at histidine's moderately nucleophilic imidazole side chain. While recent studies have demonstrated chemoselective, histidine-specific modifications by further exploiting imidazole's electrophilic reactivity to overcome interference from the more nucleophilic lysine and cysteine, achieving site-specific histidine modifications remains a major challenge due to the absence of spatial control over chemical processes. Herein, through X-ray crystallography and cryo-electron microscopy structural studies, we describe the rational design of a nature-inspired, noncanonical amino-acid-incorporated, human ferritin-based metalloenzyme that is capable of introducing site-specific post-translational modifications (PTMs) to histidine in peptides and proteins. Specifically, chemoenzymatic aza-Michael additions on single histidine residues were carried out on eight protein substrates ranging from 10 to 607 amino acids including the insulin peptide hormone. By introducing an insulin-targeting peptide into our metalloenzyme, we further directed modifications to be carried out site-specifically on insulin's B-chain histidine 5. The success of this biocatalysis platform outlines a novel approach in introducing residue- and, moreover, site-specific post-translational modifications to peptides and proteins, which may further enable reactions to be carried out

Indexed as

FerritinsHistidineMetalloproteinsAza CompoundsCrystallography, X-RayHumansModels, MolecularProtein Processing, Post-TranslationalAza CompoundsFerritinsHistidineMetalloproteins

Identifiers

PMID39499210
PMCPMC11638945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.